Quoin Pharmaceuticals Gets US Notice of Allowance for Netherton Syndrome Patent Application

Patent ExpiryapprovedPositive

AI Analysis

Summary

Quoin Pharmaceuticals received a US Notice of Allowance for a patent application related to Netherton Syndrome, strengthening its intellectual property position in this rare skin disorder indication.

Outcome Details

US Notice of Allowance for Netherton Syndrome patent application

Importance:5/10

Sentiment:

0.60

patentintellectual propertyNetherton Syndromeregulatory

Related Companies

$QNRX

Read the original article

Published by yahoo_finance on June 30, 2026 1:19 PM

Read Original